Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Current Leases (2011 - 2012)

Acadia Pharmaceuticals (ACAD) posted Current Leases of $3000.0 for Q3 2012, down 76.92% on a QoQ basis from $13000.0 in Q2 2012.

Analysis

Acadia Pharmaceuticals (ACAD) Current Leases (2011 - 2012) Analysis & Trends

Acadia Pharmaceuticals has reported Current Leases for 2 years, with the latest figure at $3000.0 in Q3 2012.

  • On a quarterly basis, Current Leases changed N/A year-over-year to $3000.0 in Q3 2012; TTM through Sep 2012 was $3000.0, a N/A change from a year earlier, with the FY2011 full-year figure at $32000.0, changed N/A from the prior year.
  • Current Leases was $3000.0 for Q3 2012 at Acadia Pharmaceuticals, down from $13000.0 in the prior quarter.
  • The five-year high for Current Leases was $32000.0 in Q4 2011, with the low at $3000.0 in Q3 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -2.32 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 3,000.00
Jun 30, 2012 13,000.00
Dec 31, 2011 32,000.00
API Access

Acadia Pharmaceuticals Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ACAD&period=max&api_key=YOUR_API_KEY